Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time meets protein corona: the Vroman effect dictates macrophage recognition of PEGylated nanoparticles.

International journal of biological macromolecules·2026
Same author

A third-generation rhodium-based nanophotosensitizer for precision photodynamic cancer therapy.

Journal of colloid and interface science·2026
Same author

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

Mesoporous Bioactive Glasses: A Powerful Tool in Tissue Engineering and Drug Delivery.

Advanced healthcare materials·2025
Same author

In vivo antimicrobial activity of engineered mesoporous silica nanoparticles targeting intracellular mycobacteria.

Nature communications·2025
Same author

Mucolytic and antibiotic combination therapy using silica-based nanocarriers to eradicate <i>Escherichia coli</i> biofilms.

Nanoscale advances·2025

Related Experiment Video

Updated: Mar 5, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K

Smart Mesoporous Nanomaterials for Antitumor Therapy.

Marina Martínez-Carmona1,2,3, Montserrat Colilla4,5,6, Maria Vallet-Regí7,8,9

  • 1Department of Inorganic and Bioinorganic Chemistry, Faculty of Pharmacy, Complutense University of Madrid, Sanitary Research Institute "Hospital 12 de Octubre" i+12, Ramón y Cajal Square, S/N, Madrid 28040, Spain. marinm11@ucm.es.

Nanomaterials (Basel, Switzerland)
|March 29, 2017
PubMed
Summary

Mesoporous silica nanoparticles (MSNs) offer advanced drug delivery for solid tumors. These smart nanocarriers target tumors and release drugs controllably, improving cancer therapy with fewer side effects.

Keywords:
active targetingcancer treatmentmesoporous silica nanoparticlespassive targetingstimuli-responsive drug delivery

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

829
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.3K

Related Experiment Videos

Last Updated: Mar 5, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

829
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.3K

Area of Science:

  • Nanomedicine
  • Materials Science
  • Oncology

Background:

  • Solid tumors are a major focus in cancer research.
  • Conventional chemotherapy has significant side effects.
  • Nanomaterials offer potential for targeted drug delivery.

Purpose of the Study:

  • To review recent advances in mesoporous silica nanoparticles (MSNs) for antitumor therapy.
  • To highlight the design of multifunctional nanosystems for enhanced cancer treatment efficacy.

Main Methods:

  • Utilizing mesoporous silica nanoparticles (MSNs) as drug nanocarriers.
  • Functionalizing MSNs with targeting ligands for tumor selectivity.
  • Employing stimuli-responsive nanogates to control drug release.

Main Results:

  • MSNs can host, transport, and protect drug molecules.
  • Targeting ligands enable selective accumulation at tumor tissues.
  • Stimuli-responsive nanogates facilitate controlled drug release upon specific triggers.

Conclusions:

  • Smart MSNs represent a promising alternative to conventional chemotherapy.
  • Multifunctional nanosystems can increase the efficacy of antitumor treatments.
  • MSNs offer a targeted and controlled approach to cancer therapy.